Andrea Cavalcanti
Overview
Explore the profile of Andrea Cavalcanti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Acidi B, Faron M, Mir O, Levy A, Ghallab M, Kasraoui I, et al.
J Visc Surg
. 2025 Feb;
PMID: 40000299
Introduction: Surgery is the cornerstone treatment for retroperitoneal sarcomas (RPS). However, contraindications for unresectability are not well-documented in the literature. Aim Of The Study: This study aims to identify contraindications...
2.
Watson S, Verret B, Ropert S, Adam J, Bahleda R, Briand S, et al.
Cancer Med
. 2022 Aug;
12(3):3160-3166.
PMID: 35971325
Gemcitabine has shown clinical activity against angiosarcoma in small series, alone, or combined with taxanes. We aimed to evaluate its activity as a single-agent in a larger series of patients...
3.
Levy A, Honore C, Dumont S, Bourdais R, Cavalcanti A, Faron M, et al.
Bull Cancer
. 2021 Jul;
108(9):868-876.
PMID: 34246458
Radiation therapy is a standard treatment for limbs soft tissue sarcomas. Preoperative versus postoperative radiotherapy has been a controversial topic for years. With preoperative irradiation, the treatment volume is more...
4.
Bourdais R, Achkar S, Honore C, Faron M, Cavalcanti A, Auzac G, et al.
Clin Transl Radiat Oncol
. 2021 Jun;
29:79-84.
PMID: 34179521
Aim: To prospectively assess toxicities of curative-intent intensity-modulated conformal radiotherapy (IMRT) in patients with extremity soft tissue sarcomas (ESTS). Methods: Data from 59 consecutive patients with ESTS between 2014 and...
5.
Charles C, Vaz Luis I, Chiesa S, Boiron C, Bourgier C, Cavalcanti A, et al.
Bull Cancer
. 2021 May;
108(7-8):740-750.
PMID: 33934893
Introduction: Fatigue is a frequent and disturbing symptom in oncology but remains undertreated. Given the absence of effective drug treatment, non-pharmacological interventions have a prominent place in the treatment of...
6.
Mir O, Honore C, Chamseddine A, Domont J, Dumont S, Cavalcanti A, et al.
Clin Cancer Res
. 2020 Sep;
26(23):6277-6283.
PMID: 32873570
Purpose: Desmoid-type fibromatosis (DF) are locally aggressive neoplasms, with a need for effective systemic treatment in case of progression to avoid the short- and long-term complications of local treatments. Experimental...
7.
Escande A, Haie-Meder C, Mazeron R, Maroun P, Cavalcanti A, de Crevoisier R, et al.
Int J Radiat Oncol Biol Phys
. 2017 May;
99(3):563-570.
PMID: 28501419
Purpose: To report the largest experience with brachytherapy as a conservative approach for the treatment of penile carcinoma. Methods And Materials: We examined the outcomes of 201 patients treated at...
8.
Ziani L, Ben Safta-Saadoun T, Gourbeix J, Cavalcanti A, Robert C, Favre G, et al.
Oncotarget
. 2017 Apr;
8(12):19780-19794.
PMID: 28423623
Cancer-associated fibroblasts (CAFs) play a central role in the complex process of tumor-stroma interaction and promote tumor growth. Emerging evidences also suggest that these fibroblasts are involved in the alteration...
9.
Verret B, Honore C, Dumont S, Terrier P, Adam J, Cavalcanti A, et al.
Anticancer Drugs
. 2016 Oct;
28(1):116-119.
PMID: 27782906
Desmoplastic small round cell tumor (DSRCT) is a rare and aggressive malignancy that occurs with unpredictable chemosensitivity and limited treatment options in the advanced setting. Prognosis is poor, and exploring...
10.
Jacquelot N, Enot D, Flament C, Vimond N, Blattner C, Pitt J, et al.
J Clin Invest
. 2016 Feb;
126(3):921-37.
PMID: 26854930
Melanoma prognosis is dictated by tumor-infiltrating lymphocytes, the migratory and functional behavior of which is guided by chemokine or cytokine gradients. Here, we retrospectively analyzed the expression patterns of 9...